Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

Due to the positive association between neoadjuvant chemotherapy (NACT) and the promising early response rates of patients with triple negative breast cancer (TNBC), including probabilities of pathological complete response, NACT is increasingly used in TNBC management. Liquid biopsy-based biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritter, Andrea, Hirschfeld, Marc, Berner, Kai, Rücker, Gerta, Jäger, Markus, Weiss, Daniela, Medl, Markus, Nöthling, Claudia, Gassner, Sandra, Asberger, Jasmin, Erbes, Thalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910196/
https://www.ncbi.nlm.nih.gov/pubmed/31789396
http://dx.doi.org/10.3892/ijo.2019.4920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910196/
https://www.ncbi.nlm.nih.gov/pubmed/31789396
http://dx.doi.org/10.3892/ijo.2019.4920

Ejemplares similares